Skip to content
Home/Companies/Biotech/Launch Therapeutics
LT

Launch Therapeutics

Biotech·US·Active·4yr hold

Launch Therapeutics is a biotech company, headquartered in US.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Launch Therapeutics?

Launch Therapeutics is currently owned by Abingworth through Abingworth Clinical Co-Development Fund 2 (2021 vintage), since 2022.

Hand-verified · updated 2026-07-08

Abingworth
Investor
Abingworth
Abingworth Clinical Co-Development Fund 2 · 2021 · Life Sciences VC

Key facts

HQUS
SectorBiotech
StatusActive

More from Abingworth Clinical Co-Development Fund 2

Other portfolio companies in the same fund.

Opthea
Active
BiotechAustralia· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings